117 related articles for article (PubMed ID: 35331907)
21. Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors.
George J; Chen Y; Abdelfattah N; Yamamoto K; Gallup TD; Adamson SI; Rybinski B; Srivastava A; Kumar P; Lee MG; Baskin DS; Jiang W; Choi JM; Flavahan W; Chuang JH; Kim BY; Xu J; Jung SY; Yun K
Cancer Res Commun; 2022 Jun; 2(6):402-416. PubMed ID: 36688010
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide.
Ghorbanlou M; Moradi F; Shabani R; Mehdizadeh M
J Chemother; 2023 Dec; ():1-14. PubMed ID: 38130211
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma.
Nellan A; Jackson S
Neuro Oncol; 2024 Apr; 26(4):623-624. PubMed ID: 38290484
[No Abstract] [Full Text] [Related]
24. Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.
Coulter DW; Chhonker YS; Kumar D; Kesherwani V; Aldhafiri WN; McIntyre EM; Alexander G; Ray S; Joshi SS; Li R; Murry DJ; Chaturvedi NK
J Exp Clin Cancer Res; 2024 Jan; 43(1):18. PubMed ID: 38200580
[TBL] [Abstract][Full Text] [Related]
25. Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma.
Mariotto E; Rampazzo E; Bortolozzi R; Rruga F; Zeni I; Manfreda L; Marchioro C; Canton M; Cani A; Magni R; Luchini A; Bresolin S; Viola G; Persano L
Acta Neuropathol Commun; 2023 Nov; 11(1):183. PubMed ID: 37978570
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Phoenix TN; Patmore DM; Boop S; Boulos N; Jacus MO; Patel YT; Roussel MF; Finkelstein D; Goumnerova L; Perreault S; Wadhwa E; Cho YJ; Stewart CF; Gilbertson RJ
Cancer Cell; 2016 Apr; 29(4):508-522. PubMed ID: 27050100
[TBL] [Abstract][Full Text] [Related]
27. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics.
Sokolov D; Sharda N; Banerjee A; Denisenko K; Basalious EB; Shukla H; Waddell J; Hamdy NM; Banerjee A
Curr Pharm Des; 2024; 30(1):31-47. PubMed ID: 38151840
[TBL] [Abstract][Full Text] [Related]
28. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma.
Badodi S; Pomella N; Lim YM; Brandner S; Morrison G; Pollard SM; Zhang X; Zabet NR; Marino S
Neuro Oncol; 2022 Aug; 24(8):1273-1285. PubMed ID: 35213723
[TBL] [Abstract][Full Text] [Related]
29. Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3.
Fallon I; Hernando H; Almacellas-Rabaiget O; Marti-Fuster B; Spadoni C; Bigner DD; Méndez E
SLAS Discov; 2024 Mar; 29(2):100147. PubMed ID: 38355016
[TBL] [Abstract][Full Text] [Related]
30. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
[TBL] [Abstract][Full Text] [Related]
31. A Simple and Scalable Zebrafish Model of Sonic Hedgehog Medulloblastoma.
Casey MJ; Chan PP; Li Q; Jette CA; Kohler M; Myers BR; Stewart RA
bioRxiv; 2024 Feb; ():. PubMed ID: 38370799
[TBL] [Abstract][Full Text] [Related]
32. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
Cell Rep; 2021 Jun; 35(13):109302. PubMed ID: 34192534
[TBL] [Abstract][Full Text] [Related]
33. The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.
Miele E; Valente S; Alfano V; Silvano M; Mellini P; Borovika D; Marrocco B; Po A; Besharat ZM; Catanzaro G; Battaglia G; Abballe L; Zwergel C; Stazi G; Milite C; Castellano S; Tafani M; Trapencieris P; Mai A; Ferretti E
Oncotarget; 2017 Sep; 8(40):68557-68570. PubMed ID: 28978137
[TBL] [Abstract][Full Text] [Related]
34. Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.
Li Y; Lim C; Dismuke T; Malawsky DS; Oasa S; Bruce ZC; Offenhäuser C; Baumgartner U; D'Souza RCJ; Edwards SL; French JD; Ock LSH; Nair S; Sivakumaran H; Harris L; Tikunov AP; Hwang D; Del Mar Alicea Pauneto C; Maybury M; Hassall T; Wainwright B; Kesari S; Stein G; Piper M; Johns TG; Sokolsky-Papkov M; Terenius L; Vukojević V; Gershon TR; Day BW
Res Sq; 2023 Jun; ():. PubMed ID: 37333134
[TBL] [Abstract][Full Text] [Related]
35. Homeodomain Transcription Factors Nkx2.2 and Pax6 as Novel Biomarkers for Meningioma Tumor Treatment.
Farheen S; Pm MM; Rehman S; Hoda MF; Gupta Y; Ali A; Chosdol K; Shahi MH
Indian J Clin Biochem; 2024 Jan; 39(1):47-59. PubMed ID: 38223000
[TBL] [Abstract][Full Text] [Related]
36. Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.
Motahari Z; Lepe JJ; Bautista MR; Hoerig C; Plant-Fox AS; Das B; Fowler CD; Magge SN; Bota DA
bioRxiv; 2024 Mar; ():. PubMed ID: 38464047
[TBL] [Abstract][Full Text] [Related]
37. High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma.
Zhou L; van Bree N; Boutin L; Ryu J; Moussaud S; Liu M; Otrocka M; Olsson M; Falk A; Wilhelm M
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38860311
[TBL] [Abstract][Full Text] [Related]
38. Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.
Bonfim-Silva R; Salomão KB; Pimentel TVCA; Menezes CCBO; Palma PVB; Fontes AM
Cytotechnology; 2019 Oct; 71(5):893-903. PubMed ID: 31346954
[TBL] [Abstract][Full Text] [Related]
39. Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.
Mendelson NL; Al Assaad M; Hadi K; Manohar J; Sigouros M; Sboner A; Medina-Martínez JS; Elemento O; Jessurun J; Mosquera JM
Am J Surg Pathol; 2023 Oct; 47(10):1192-1193. PubMed ID: 37489101
[No Abstract] [Full Text] [Related]
40. Thyroid Hormone Suppresses Medulloblastoma Progression Through Promoting Terminal Differentiation of Tumor Cells.
Yang Y; Valdés-Rives SA; Liu Q; Li Y; Tan J; Tan Y; Koch CA; Rong Y; Houser SR; Wei S; Cai KQ; Cheng SY; Curran T; Wechsler-Reya R; Yang ZJ
bioRxiv; 2024 Feb; ():. PubMed ID: 38405864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
